301509 金凯生科
交易中 07-25 13:35:42
资讯
新帖
简况
金凯生科：截至2025年7月18日股东数为13,837户
证券之星 · 07-21
金凯生科：截至2025年7月18日股东数为13,837户
金凯生科(301509)7月10日股东户数1.55万户，较上期增加11.88%
证券之星 · 07-14
金凯生科(301509)7月10日股东户数1.55万户，较上期增加11.88%
【减肥药概念持续走高，常山药业“20cm”涨停】 减肥药概念持续走高，常山药业“20cm”涨停，凯莱英、美迪西、金凯生科、博瑞医药、诺泰生物、纳微科技等跟涨。
金融界 · 07-11
【减肥药概念持续走高，常山药业“20cm”涨停】 减肥药概念持续走高，常山药业“20cm”涨停，凯莱英、美迪西、金凯生科、博瑞医药、诺泰生物、纳微科技等跟涨。
金凯生科股价微跌0.31% 公司回应氟化产品应用领域
金融界 · 07-09
金凯生科股价微跌0.31% 公司回应氟化产品应用领域
金凯生科：公司氟化产品主要应用于医药与农药领域
证券之星 · 07-09
金凯生科：公司氟化产品主要应用于医药与农药领域
金凯生科：截至6月30日股东数为13,817户
证券之星 · 07-01
金凯生科：截至6月30日股东数为13,817户
金凯生科：截至2025年6月20日股东数为13,826户
证券之星 · 06-25
金凯生科：截至2025年6月20日股东数为13,826户
金凯生科(301509)6月20日股东户数1.38万户，较上期减少13.81%
证券之星 · 06-23
金凯生科(301509)6月20日股东户数1.38万户，较上期减少13.81%
金凯生科：公司定位为面向全球生命科技领域客户的小分子CDMO服务商
证券之星 · 06-18
金凯生科：公司定位为面向全球生命科技领域客户的小分子CDMO服务商
每周股票复盘：金凯生科（301509）股东户数减少1350户，户均持股增至7508股
证券之星 · 06-13
每周股票复盘：金凯生科（301509）股东户数减少1350户，户均持股增至7508股
金凯生科(301509)6月10日股东户数1.6万户，较上期减少7.76%
证券之星 · 06-11
金凯生科(301509)6月10日股东户数1.6万户，较上期减少7.76%
生物科技概念盘中拉升，金凯生科涨4.47%
市场透视 · 06-10
生物科技概念盘中拉升，金凯生科涨4.47%
每周股票复盘：金凯生科（301509）股东户数增加1400户，增幅8.75%
证券之星 · 06-07
每周股票复盘：金凯生科（301509）股东户数增加1400户，增幅8.75%
金凯生科：截至2025年5月30日，公司股东数为17,392户
证券之星 · 06-04
金凯生科：截至2025年5月30日，公司股东数为17,392户
金凯生科：公司产品主要应用于医药、农药等领域
证券之星 · 05-29
金凯生科：公司产品主要应用于医药、农药等领域
每周股票复盘：金凯生科（301509）股东户数减少1969户，户均持股增至7532股
证券之星 · 05-23
每周股票复盘：金凯生科（301509）股东户数减少1969户，户均持股增至7532股
金凯生科5月22日现1笔大宗交易 总成交金额1496.95万元 其中机构买入1496.95万元 溢价率为-1.40%
新浪证券-红岸工作室 · 05-22
金凯生科5月22日现1笔大宗交易 总成交金额1496.95万元 其中机构买入1496.95万元 溢价率为-1.40%
金凯生科(301509)5月20日股东户数1.6万户，较上期减少10.96%
证券之星 · 05-21
金凯生科(301509)5月20日股东户数1.6万户，较上期减少10.96%
【CRO概念板块短线拉升 河化股份涨停】CRO概念板块短线拉升，河化股份涨停，金凯生科、睿智医药、诺思格、昊帆生物、义翘神州等纷纷走高。
金融界 · 05-21
【CRO概念板块短线拉升 河化股份涨停】CRO概念板块短线拉升，河化股份涨停，金凯生科、睿智医药、诺思格、昊帆生物、义翘神州等纷纷走高。
金凯生科(301509.SZ)股东蓝区基金拟减持不超3%股份
智通财经 · 05-15
金凯生科(301509.SZ)股东蓝区基金拟减持不超3%股份
加载更多
公司概况
公司名称：
金凯(辽宁)生命科技股份有限公司
所属行业：
医药制造业
上市日期：
2023-08-03
主营业务：
金凯(辽宁)生命科技股份有限公司的主营业务是为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司的主要产品是含氟类CDMO业务、非含氟类CDMO业务。
发行价格：
56.56
{"stockData":{"symbol":"301509","market":"SZ","secType":"STK","nameCN":"金凯生科","latestPrice":38.33,"timestamp":1753421742000,"preClose":38.62,"halted":0,"volume":3786980,"delay":0,"changeRate":-0.0075,"floatShares":56740900,"shares":120000000,"eps":0.5753,"marketStatus":"交易中","change":-0.29,"latestTime":"07-25 13:35:42","open":38.5,"high":39.06,"low":37.87,"amount":146000000,"amplitude":0.0308,"askPrice":38.33,"askSize":11,"bidPrice":38.32,"bidSize":15,"shortable":0,"etf":0,"ttmEps":0.5753,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753426800000},"marketStatusCode":2,"adr":0,"adjPreClose":38.62,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":42.48,"lowLimit":34.76,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120446669,"isCdr":false,"pbRate":2.12,"roa":"--","peRate":66.626108,"roe":"2.18%","epsLYR":0.32,"committee":-0.259259,"marketValue":4617000000,"turnoverRate":0.0667,"status":1,"floatMarketCap":2175000000},"requestUrl":"/m/hq/s/301509","defaultTab":"news","newsList":[{"id":"2553248024","title":"金凯生科：截至2025年7月18日股东数为13,837户","url":"https://stock-news.laohu8.com/highlight/detail?id=2553248024","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553248024?lang=zh_cn&edition=full","pubTime":"2025-07-21 15:54","pubTimestamp":1753084452,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问7月20日的股东户数是多少？金凯生科回复：尊敬的投资者，您好！截至2025年7月18日，公司股东数为13,837户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100017662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2551901308","title":"金凯生科(301509)7月10日股东户数1.55万户，较上期增加11.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551901308","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551901308?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:13","pubTimestamp":1752484416,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2025年7月10日公司股东户数为1.55万户，较6月30日增加1642.0户，增幅为11.88%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至7月10日，医疗服务行业平均股东户数为4.45万户。从股价来看，2025年6月30日至2025年7月10日，金凯生科区间涨幅为3.55%，在此期间股东户数增加1642.0户，增幅为11.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400024512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2550605433","title":"【减肥药概念持续走高，常山药业“20cm”涨停】 减肥药概念持续走高，常山药业“20cm”涨停，凯莱英、美迪西、金凯生科、博瑞医药、诺泰生物、纳微科技等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550605433","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550605433?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:57","pubTimestamp":1752199038,"startTime":"0","endTime":"0","summary":"减肥药概念持续走高，常山药业“20cm”涨停，凯莱英、美迪西、金凯生科、博瑞医药、诺泰生物、纳微科技等跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/11095751620113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2488822045.USD","BK0229","BK0239","LU1328615791.USD","06821","688166","BK0132","301509","002821","300255","688076","BK0172","BK0216","BK1191","BK0070","688690","688202"],"gpt_icon":0},{"id":"2550657184","title":"金凯生科股价微跌0.31% 公司回应氟化产品应用领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2550657184","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550657184?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:52","pubTimestamp":1752083563,"startTime":"0","endTime":"0","summary":"金凯生科7月9日股价报38.08元，较前一交易日下跌0.12元，跌幅0.31%。当日开盘价为37.86元，最高触及39.13元，最低下探37.20元，成交量为63412手，成交金额达2.42亿元。金凯生科是一家专注于生命科学领域小分子CDMO业务的企业，主要提供医药和农药领域的氟化产品。公司在互动平台表示，其氟化产品主要应用于医药与农药领域，目前不涉及固态电池材料领域。7月9日主力资金净流出821.52万元，占流通市值的0.38%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/10015251595904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2550422572","title":"金凯生科：公司氟化产品主要应用于医药与农药领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2550422572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550422572?lang=zh_cn&edition=full","pubTime":"2025-07-09 09:01","pubTimestamp":1752022881,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科07月08日在投资者关系平台上答复投资者关心的问题。公司氟化产品主要应用于医药与农药领域，目前不涉及固态电池材料领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900006064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","301509","BK0239","BK1515","BK1161","159938","09939"],"gpt_icon":0},{"id":"2548073480","title":"金凯生科：截至6月30日股东数为13,817户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548073480","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548073480?lang=zh_cn&edition=full","pubTime":"2025-07-01 15:51","pubTimestamp":1751356263,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止6月30日股东人数是多少？谢谢金凯生科回复：尊敬的投资者，您好！截至2025年6月30日，公司股东数为13,817户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100022997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2546525245","title":"金凯生科：截至2025年6月20日股东数为13,826户","url":"https://stock-news.laohu8.com/highlight/detail?id=2546525245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546525245?lang=zh_cn&edition=full","pubTime":"2025-06-25 08:46","pubTimestamp":1750812372,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，你好!请问截止至2025年6月20日，公司股东人数总数是多少?谢谢!金凯生科回复：尊敬的投资者，您好！截至2025年6月20日，公司股东数为13,826户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500007404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2545494974","title":"金凯生科(301509)6月20日股东户数1.38万户，较上期减少13.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545494974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545494974?lang=zh_cn&edition=full","pubTime":"2025-06-23 17:16","pubTimestamp":1750670170,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2025年6月20日公司股东户数为1.38万户，较6月10日减少2216.0户，减幅为13.81%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至6月20日，医疗服务行业平均股东户数为4.45万户。从股价来看，2025年6月10日至2025年6月20日，金凯生科区间跌幅为12.99%，在此期间股东户数减少2216.0户，减幅为13.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300021244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2544929767","title":"金凯生科：公司定位为面向全球生命科技领域客户的小分子CDMO服务商","url":"https://stock-news.laohu8.com/highlight/detail?id=2544929767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544929767?lang=zh_cn&edition=full","pubTime":"2025-06-18 16:30","pubTimestamp":1750235447,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司现有业务和未来业务规划中，是否设计创新药的研发或生产。谢谢。金凯生科回复：尊敬的投资者，您好！公司定位为面向全球生命科技领域客户的小分子 CDMO 服务商，为客户的新药研发项目提供定制研发生产服务，参与解决其创新药研发过程中有关化合物合成的工艺开发、工艺优化、工艺放大和规模化生产等环节需求。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800024745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2543632753","title":"每周股票复盘：金凯生科（301509）股东户数减少1350户，户均持股增至7508股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543632753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543632753?lang=zh_cn&edition=full","pubTime":"2025-06-14 03:36","pubTimestamp":1749843377,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘，金凯生科报收于37.56元，较上周的35.04元上涨7.19%。本周，金凯生科6月10日盘中最高价报42.0元，股价触及近一年最高点。本周关注点股本股东变化：截至2025年6月10日公司股东户数为1.6万户，较5月30日减少1350.0户，减幅为7.76%股本股东变化：户均持股数量由上期的6925.0股增加至7508.0股股本股东变化近日金凯生科披露，截至2025年6月10日公司股东户数为1.6万户，较5月30日减少1350.0户，减幅为7.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400008064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2542930497","title":"金凯生科(301509)6月10日股东户数1.6万户，较上期减少7.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542930497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542930497?lang=zh_cn&edition=full","pubTime":"2025-06-11 17:17","pubTimestamp":1749633421,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2025年6月10日公司股东户数为1.6万户，较5月30日减少1350.0户，减幅为7.76%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至6月10日，医疗服务行业平均股东户数为4.43万户。从股价来看，2025年5月30日至2025年6月10日，金凯生科区间涨幅为7.12%，在此期间股东户数减少1350.0户，减幅为7.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100026462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2542362561","title":"生物科技概念盘中拉升，金凯生科涨4.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542362561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542362561?lang=zh_cn&edition=full","pubTime":"2025-06-10 13:45","pubTimestamp":1749534346,"startTime":"0","endTime":"0","summary":"06月10日，生物科技概念盘中拉升，截至13点45分，生物科技概念整体指数上涨0.53%，报836.840点。从个股上来看，该概念的成分股中，金凯生科涨4.47%，生物股份、瑞普生物涨幅居前。从资金上来看，截止发稿，生物科技概念主力净流入为-2.36亿，其中瑞普生物受到资金热捧，主力净流入2631.32万；拉长时间线来看，该板块近20日主力资金净流入-8.06亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101345469778f2ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506101345469778f2ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0012","BK0028","BK0188","BK0239","BK0185","BK0196","159837","301509","600201","BK0046"],"gpt_icon":0},{"id":"2541189618","title":"每周股票复盘：金凯生科（301509）股东户数增加1400户，增幅8.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541189618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541189618?lang=zh_cn&edition=full","pubTime":"2025-06-07 12:30","pubTimestamp":1749270631,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘，金凯生科报收于35.04元，较上周的37.22元下跌5.86%。本周，金凯生科6月3日盘中最高价报40.5元。金凯生科当前最新总市值42.2亿元，在医疗服务板块市值排名34/50，在两市A股市值排名3396/5148。本周关注点股本股东变化：截至2025年5月30日公司股东户数为1.74万户，较5月20日增加1400户，增幅为8.75%股本股东变化近日金凯生科披露，截至2025年5月30日公司股东户数为1.74万户，较5月20日增加1400.0户，增幅为8.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700010747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2540806320","title":"金凯生科：截至2025年5月30日，公司股东数为17,392户","url":"https://stock-news.laohu8.com/highlight/detail?id=2540806320","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540806320?lang=zh_cn&edition=full","pubTime":"2025-06-04 11:37","pubTimestamp":1749008228,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止5月31日股东人数是多少，谢谢金凯生科回复：尊敬的投资者，您好！截至2025年5月30日，公司股东数为17,392户。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400013096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2539231678","title":"金凯生科：公司产品主要应用于医药、农药等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2539231678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539231678?lang=zh_cn&edition=full","pubTime":"2025-05-29 15:57","pubTimestamp":1748505425,"startTime":"0","endTime":"0","summary":"证券之星消息，金凯生科(301509)05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司布局有哪些具有潜力的新兴产品和方向？金凯生科回复：尊敬的投资者，您好！公司是一家面向全球生命科技领域客户的小分子 CDMO 服务商，产品主要应用于医药、农药等领域，医药核心产品终端药物涉及肿瘤、心脑血管、糖尿病、肾脏疾病、白血病、贫血症、免疫系统疾病等多个疾病治疗领域；农药核心产品终端药物涉及杀虫剂、杀菌剂等领域。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900020740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0239","159938","09939","BK1161","301509","BK1574"],"gpt_icon":0},{"id":"2537115706","title":"每周股票复盘：金凯生科（301509）股东户数减少1969户，户均持股增至7532股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537115706","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537115706?lang=zh_cn&edition=full","pubTime":"2025-05-24 05:36","pubTimestamp":1748036179,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘，金凯生科报收于36.7元，较上周的33.03元上涨11.11%。本周，金凯生科5月23日盘中最高价报39.48元。5月19日盘中最低价报32.25元。金凯生科当前最新总市值44.2亿元，在医疗服务板块市值排名31/50，在两市A股市值排名3179/5148。股本股东变化近日金凯生科披露，截至2025年5月20日公司股东户数为1.6万户，较5月9日减少1969.0户，减幅为10.96%。户均持股数量由上期的6706.0股增加至7532.0股，户均持股市值为25.74万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400008529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2537916365","title":"金凯生科5月22日现1笔大宗交易 总成交金额1496.95万元 其中机构买入1496.95万元 溢价率为-1.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537916365","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537916365?lang=zh_cn&edition=full","pubTime":"2025-05-22 17:00","pubTimestamp":1747904400,"startTime":"0","endTime":"0","summary":" 5月22日，金凯生科收涨2.42%，收盘价为37.21元，发生1笔大宗交易，合计成交量40.8万股，成交金额1496.95万元。 第1笔成交价格为36.69元，成交40.80万股，成交金额1,496.95万元，溢价率为-1.40%，买方营业部为机构专用，卖方营业部为中信证券(山东)有限责任公司青岛秦岭路证券营业部。 进一步统计，近3个月内该股累计发生8笔大宗交易，合计成交金额为3630.89万元。该股近5个交易日累计上涨10.42%，主力资金合计净流出1647.32万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-05-22/doc-inexmssx4927012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2537988238","title":"金凯生科(301509)5月20日股东户数1.6万户，较上期减少10.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537988238","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537988238?lang=zh_cn&edition=full","pubTime":"2025-05-21 17:20","pubTimestamp":1747819200,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金凯生科披露，截至2025年5月20日公司股东户数为1.6万户，较5月9日减少1969.0户，减幅为10.96%。在医疗服务行业个股中，金凯生科股东户数低于行业平均水平，截至5月20日，医疗服务行业平均股东户数为4.39万户。从股价来看，2025年5月9日至2025年5月20日，金凯生科区间跌幅为4.04%，在此期间股东户数减少1969.0户，减幅为10.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100027921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2537673118","title":"【CRO概念板块短线拉升 河化股份涨停】CRO概念板块短线拉升，河化股份涨停，金凯生科、睿智医药、诺思格、昊帆生物、义翘神州等纷纷走高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537673118","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537673118?lang=zh_cn&edition=full","pubTime":"2025-05-21 09:46","pubTimestamp":1747791988,"startTime":"0","endTime":"0","summary":"CRO概念板块短线拉升，河化股份涨停，金凯生科、睿智医药、诺思格、昊帆生物、义翘神州等纷纷走高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21094650553907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","301509","BK0010","BK0239","301333","BK0004","BK0216","301393","300149","000953","BK0071","BK0229","BK0066","301047"],"gpt_icon":0},{"id":"2535844498","title":"金凯生科(301509.SZ)股东蓝区基金拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2535844498","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535844498?lang=zh_cn&edition=full","pubTime":"2025-05-15 20:01","pubTimestamp":1747310495,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金凯生科(301509.SZ)公告，公司股东蓝色经济区产业投资基金(有限合伙)(简称“蓝区基金”)计划通过集中竞价和大宗交易方式减持公司股份不超过361.2万股(占公司总股本比例3%)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301509"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753421747461,"stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":0.0972},{"period":"3month","weight":0.2731},{"period":"6month","weight":0.6017},{"period":"1year","weight":0.3015},{"period":"ytd","weight":0.5082}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0541},{"period":"3month","weight":0.0943},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.2425},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金凯(辽宁)生命科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"13837人(较上一季度减少10.49%)","perCapita":"4100股","listingDate":"2023-08-03","address":"辽宁省阜新市阜新蒙古族自治县伊吗图镇氟化工园区安仁路6号","registeredCapital":"12044万元","survey":" 金凯(辽宁)生命科技股份有限公司的主营业务是为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司的主要产品是含氟类CDMO业务、非含氟类CDMO业务。","listedPrice":56.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金凯生科,301509,金凯生科股票,金凯生科股票老虎,金凯生科股票老虎国际,金凯生科行情,金凯生科股票行情,金凯生科股价,金凯生科股市,金凯生科股票价格,金凯生科股票交易,金凯生科股票购买,金凯生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}